-
New ACP Migraine Guidelines Show No Advantage for Pricy, Newer Medications
06 Feb 2025 20:29 GMT
… pharmacologic treatments.
Many pharmacologic treatments for … The FDA has approved some drugs for migraine … blockers (candesartan and telmisartan)
Antiseizure medications (valproate and topiramate … and venlafaxine)
Tricyclic antidepressant (amitriptyline)
The …
-
Optimizing Episodic Migraine Care: ACP’s Latest Treatment Guidance
05 Feb 2025 05:42 GMT
… trials that were least 12 weeks long, encompassing treatment … and telmisartan
Antiseizure medications: topiramate … antidepressants (TCAs): amitriptyline
Treatment combinations … treatment AEs
Switch treatments, typically within 2 to 3 months, if a trial …
-
Health Expert Highlights Drug Prices in Indonesia That Are 6 Times Higher Than India
27 Jan 2025 19:30 GMT
… prices for medicines and medical devices for … doctor and professor friends in Indonesia asked him for medicines.
Comparison of drug … prices
His experience shows that the quality of medicines … cheaper. For Telmisartan 40 mg the …
-
Drug Alert: CDSCO Flags 51 Formulations As Not Of Standard Quality
25 Jan 2025 17:51 GMT
… TABLETS) manufactured by Uniplus Biotech and others.
Furthermore, the … M/s. Ciron Drugs & Pharmaceuticals Pvt. Ltd., N- … M/s. Nandani Medical Laboratories Pvt. Ltd., 221… and Description
Central Drugs Laboratory, Kolkata
25.
Telmisartan Tablets I. …
-
Solid Self-Microemulsifying Drug Delivery System for Improved Oral Bioavailability of Relugolix: Preparation and Evaluation
25 Jan 2025 15:12 GMT
… supersaturable self-emulsifying drug delivery systems. Pharmaceutics. 2020;12 … drug delivery system for phospholipid complex of telmisartan … their cellular reduction. Biotechnol Annu Rev. 2005 … nanomedicines for synergistic treatment of ulcerative colitis. …
-
Aussie spinout could change blood pressure paradigm with low-dose poly pill
24 Jan 2025 00:22 GMT
George Medicines, a new spinout from Australia’ … . A polypill that combines multiple medicines into a single tablet, GMRx2 … single pill is a combination of three best-in-class medicines: telmisartan, amlodipine … Small molecule Asia-Pacific Australia FDA
-
Human medicines European public assessment report (EPAR): Kinzalmono (previously Telmisartan Boehringer Ingelheim Pharma KG), telmisartan, Date of authorisation: 16/12/1998, Revision: 30, Status: Authorised
17 Jan 2025 16:50 GMT
Side effects with Kinzalmono are not common. However, the following side effects are seen in between 1 and 10 patients in 1,000: upper respiratory tract infection (colds) including inflammation of the throat and sinuses, urinary tract infection (infection …
-
Human medicines European public assessment report (EPAR): Micardis, telmisartan, Date of authorisation: 16/12/1998, Revision: 28, Status: Authorised
17 Jan 2025 16:50 GMT
Side effects with Micardis are not common. However, the following side effects are seen in between 1 and 10 patients in 1,000: upper-respiratory-tract infection (colds) including inflammation of the throat and sinuses, urinary-tract infection (infection of …
-
Algernon Pharmaceuticals Receives Notice of Allowance from USPTO For Repirinast in Kidney Disease Patent
15 Jan 2025 15:51 GMT
… or in combination with telmisartan, for the treatment or prophylaxis of renal … showed an additive benefit to telmisartan in a unilateral ureteral obstruction … company investigating multiple drugs for unmet global medical needs. Algernon Pharmaceuticals is also …
-
George Medicines signs exclusive licensing agreement with Bausch Health to commercialize GMRx2 in Canada, Mexico, Columbia and Central America
13 Jan 2025 12:00 GMT
… Health’), a global, diversified pharmaceutical company enriching lives through a … treatment, is a proprietary single-pill combination of three best-in-class medicines: telmisartan … Drug Administration (FDA) seeking US approval of GMRx2 for the treatment …
About
© 1995-2025